mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
0.33 |
0.03 |